LILRB1 and nonpapillary renal cell carcinoma: Other remarkable changes in PBNK from ccRCC patients were the increased frequencies of CD3-CD56dim cells that expressed the inhibitory receptor CD85j and the coinhibitory molecule PD-1, and the expression of higher amounts of CD45 and MHC-I on both subsets of NK cells.